CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

187 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q2 2023.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 96,771,026 shares of 416,598,522 outstanding shares and own 23.23% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (31,434,700 shares), RENAISSANCE TECHNOLOGIES LLC (8,847,780 shares), BlackRock Inc. (7,772,104 shares), CITADEL ADVISORS LLC (5,348,273 shares), PNC Financial Services Group, Inc. (5,260,816 shares), MILLENNIUM MANAGEMENT LLC (4,650,918 shares), GEODE CAPITAL MANAGEMENT, LLC (3,649,823 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2,401,673 shares), JUPITER ASSET MANAGEMENT LTD (2,365,118 shares), and Cubist Systematic Strategies, LLC (2,328,926 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.